Please assess the completion status of the following clinical trial:

Trial Title: Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Documented HIV infection~* CD4 cell count below 300/mm3~* Plasma HIV RNA over 30,000 copies/ml~* Previously treated with 2 protease inhibitors and 1 non nucleoside analogue (except amprenavir, lopinavir)~* Written informed consent~Exclusion Criteria:~* Biological abnormalities~* Pregnancy~* Alcool abuse~* History of pancreatitis, hepatic failure~* Acute HIV related infection~* Chemotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).